Smart Outreach

Smart - Outreach

The 2015 EAPM annual conference introduced the Alliance’s ‘SMART’ concept, which stands for “Smaller Member States and Regions Together”.

EAPM is convinced that the perspective of these countries, as well as regions in larger states, is extremely important when it comes to determining whether there is a case for EU-level action on health.

Smaller states has been active in shaping health policy et European level and can now act as vital policy entrepreneurs pursuing normative policy agenda.

It is clear that the EU’s smaller Member States and the regions within larger ones, find collaboration a necessity and will very likely show Europe the way when it comes to achieving this.

DOCUMENTS

Policy papers

Please see the following relevant documents

SMART Outreach - Pathways to Personalised Medicine

Objectives

Let’s dive into the specifics of our objectives and work together to turn our vision into reality.

Improving collaboration of the smaller states ad regions in health policy

Implementing legislative dossiers in individual countries

Developing a core group of stakeholders to facilitate activity on the ground in Members States and support the Alliance a EU level.

Creating a steering group of members that will meet regularly and act as a point of contact for EAPM’s work in the wider Europe to ensure that there is effectiveness and coordination in the regulatory, policy, education, and engagement arenas.

Activities

Navigate through the engaging landscape of EAPM activities, where innovation meets execution!.

EAPM will begin its "Outreach programme during 2015, and continue it into the future. This will be called "SMART Outreach - Pathways to Personalised Medicine" and this year will see three events.

Event 1 - Evolving Europe's health systems, Poland

Event 2 - MAPPs and Personalised Medicine: What are the Implications for Patients, Regulators, and Payers?, European Health Forum Gastein

Event 3 - An Inter-institutional discussion: "Personalised Medicine - The right treatment for the right patient at the right time", Bulgaria

Event 4 - New Regulatory pathways for personalised medicines, Austria